Status:

COMPLETED

The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.

Lead Sponsor:

University of Memphis

Collaborating Sponsors:

Compound Solutions Inc.

Conditions:

Stem Cells

Eligibility:

All Genders

40-70 years

Phase:

NA

Brief Summary

The goal of the study is to determine the acute and short-term supplementation effect of a commercially available theacrine-containing supplement (NAD3) on numbers of various circulating stem cell pop...

Detailed Description

This is a double-blind, placebo-controlled crossover study with 12 participants randomized to receive either NAD3® or a placebo for seven days. Blood samples are collected after an overnight fast, bef...

Eligibility Criteria

Inclusion

  • Male or Female
  • Age 40-70
  • BMI between 21-34.99 kg/m2
  • Vital signs with in normal range (heart rate 60-100 beats/minute, blood pressure (40-44 years - 125/83, 45-49 years- 127/84, 50-54 years -129/85, 55-59 years - 131/86, \>60 - 134/87), 36.4-37.4 degrees Celsius
  • Sedentary to lightly active (2 or fewer days per week of exercise)

Exclusion

  • Female participants who are lactating, pregnant or planning to become pregnant during the study
  • History of use of illicit drugs or other substances of abuse within 12 months of the screening visit (to be determined at screening)
  • Tobacco during the 90 days prior to screening
  • Current use of medication/dietary supplements that claim to or have an effect on age-related processes, e.g. "anti-aging" supplements. Participants must undergo a ≥7-day washout period of no supplementation to be eligible.
  • Known allergy, intolerance or hypersensitivity to NAD3
  • Self-reported active infection or illness of any kind
  • Cognitively impaired and/or unable to give informed consent

Key Trial Info

Start Date :

January 2 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2023

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT06219161

Start Date

January 2 2023

End Date

July 31 2023

Last Update

January 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Memphis

Memphis, Tennessee, United States, 38152